Relativity Acquisition registered to raise $125 million through an initial public offering of 12.5 million units. Each unit has an offering price of $10 and consists of one share of Class A common stock and a redeemable warrant.
The SPAC’s acquisition focus is on businesses in the legalized cannabis industry.
CEO and Chairman Tarek K. Tabsh co-founded Oxford Cannabinoid Technologies, a UK-based pharmaceutical company.
A.G.P. is sole book-running manager, and Brookline Capital Markets is co-manager of the offering.
Relativity in the filing said it has applied to list on the Nasdaq under the symbol RACYU. Read more.
